VitriVax is redefining how vaccines and therapeutics are delivered. Our ALTA® platform enables thermostable, single-shot formulations - removing cold-chain barriers and unlocking global access.
| Website | https://vitrivaxbio.com/ |
| Employees | 52 (44 on RocketReach) |
| Founded | 2017 |
| Address | 5500 Central Avenue Suite 220, Boulder, Colorado 80301, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+11 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Vaccine Technology, Vaccine Development, Vaccine Delivery, Vaccine Platform, Human Vaccines, Animal Vaccines, Biotechnology, Vaccine Manufacturing, Pharmaceutical Technology, Drug Delivery, Global Health, Cold Chain |
| Competitors | Moderna Therapeutics, Pfizer, AstraZeneca, Johnson & Johnson, Novavax, Sanofi, GSK, Merck & Co., Inc., Genentech, Regeneron +42 more (view full list) |
Looking for a particular VitriVax employee's phone or email?
Romulo Colindres is the CEO of VitriVax.
44 people are employed at VitriVax.
VitriVax is based in Boulder, Colorado.